Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Drug Manufacturers — Specialty and Generic

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for companion and food animals. It offers companion animal disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks; companion animal therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as functional nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production. The company sells its products to third-party distributors; veterinarians; and food animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations in approximately 90 countries in North America, Europe, the Middle East, Africa, Latin America, and the Asia-Pacific. The company has a research and development collaboration with AgBiome, Inc. to develop nutritional health products for swine; and strategic alliance with the Purdue University and Purdue Research Foundation. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
Website: elanco.com



Growth: Good revenue growth rate 10.4%, there is acceleration compared to average historical growth rates 0.6%. The revenue growth dynamics is unstable Site traffic for the last 3 months showed a change of -7.8%

Profitability: LTM EBITDA margin is positive, +4.3%. On average the margin is improving unsteadily. Gross margin is high, +53.4%. In the last quarter the company beat the estimated EPS, +55.2%. The company was ahead of estimated EPS in 100% of quarters (showing a gain of +$0.08 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 2.8% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 205.4% higher than minimum and 0.9% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 1.9x by EV / Sales multiple , the company can be 45.3% overvalued

Insiders: For the last 3 months insiders bought company shares on $0.9 mln (0.009% of cap.)

Key Financials (Download financials)

Ticker: ELAN
Share price, USD:  (0.0%)24.68
year average price 16.66  


year start price 11.50 2025-02-08

min close price 8.10 2025-04-16

max close price 24.91 2026-01-22

current price 24.68 2026-02-07
Common stocks: 474 095 987

Dividend Yield:  0.0%
FCF Yield LTM: 2.8%
EV / LTM EBITDA: 79.0x
EV / EBITDA annualized: 1965.6x
EV / Sales: 3.4x
Margin (EBITDA LTM / Revenue): 4.3%
Fundamental value created in LTM:
Market Cap ($m): 11 701
Net Debt ($m): 4 024
EV (Enterprise Value): 15 725
Price to Book: 1.7x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-01-22prnewswire.com

Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2025 Financial Results Announcement

2026-01-13seekingalpha.com

Elanco Animal Health Incorporated (ELAN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2025-12-31prnewswire.com

Elanco Receives USDA Approval for Befrena™ (tirnovetmab), a New Anti-IL31 Monoclonal Antibody Injection Targeting Canine Allergic and Atopic Dermatitis

2025-12-12seekingalpha.com

Elanco Animal Health Incorporated (ELAN) Analyst/Investor Day Transcript

2025-12-09prnewswire.com

Elanco Investor Day Defines New Era as Sustainable Growth Company

2025-12-03seekingalpha.com

Elanco Animal Health Incorporated (ELAN) Presents at Evercore 8th Annual Healthcare Conference Transcript

2025-11-26prnewswire.com

Elanco executive appointed as Neurizon's Board Observer

2025-11-05youtube.com

Elanco Animal Health CEO: Seeing a willingness to spend, durability even in 'consumer tested' time

2025-11-05seekingalpha.com

Elanco Animal Health Incorporated (ELAN) Q3 2025 Earnings Call Transcript

2025-11-05zacks.com

Elanco Animal Health Incorporated (ELAN) Q3 Earnings and Revenues Surpass Estimates
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol ELAN ELAN ELAN ELAN ELAN ELAN ELAN ELAN ELAN ELAN ELAN ELAN ELAN ELAN
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-05 2025-08-07 2024-11-07 2024-08-08 2024-05-08 2023-11-07 2023-08-07 2023-05-09 2022-11-08
acceptedDate 2025-11-05 09:06:32 2025-08-07 09:05:13 2025-02-25 09:12:37 2024-11-07 09:07:58 2024-08-08 09:10:02 2024-05-08 09:06:59 2024-02-26 09:05:25 2023-11-07 16:14:47 2023-08-07 16:11:14 2023-05-09 09:08:41 2023-03-01 13:00:26 2022-11-08 09:07:49 2022-02-28 14:46:11 2021-03-01 14:25:10
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 1 137M 1 241M 4 439M 1 030M 1 184M 1 205M 4 417M 1 068M 1 057M 1 257M 4 411M 1 028M 4 764M 3 273M
costOfRevenue 530M 664M 2 530M 625M 626M 515M 2 479M 487M 434M 494M 2 441M 472M 2 688M 2 027M
grossProfit 607M 577M 1 909M 405M 558M 690M 1 938M 581M 623M 763M 1 970M 556M 2 076M 1 247M
grossProfitRatio 0.534 0.465 0.393 0.471 0.573 0.544 0.589 0.607 0.541
researchAndDevelopmentExpenses 89M 92M 344M 87M 89M 87M 327M 86M 81M 81M 321M 78M 369M 327M
generalAndAdministrativeExpenses 351M 0 1 072M 0 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 236M 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 351M 400M 1 314M 323M 354M 337M 1 285M 313M 353M 327M 1 265M 298M 1 403M 997M
otherExpenses 140M 0 0 0 -2M -9M 0 -9M -23M 134M 0 128M 0 0
operatingExpenses 580M 492M 1 658M 410M 443M 557M 1 612M 539M 570M 542M 1 586M 504M 1 772M 1 324M
costAndExpenses 1 110M 1 156M 4 188M 1 035M 1 069M 1 072M 4 091M 1 026M 1 004M 1 036M 4 027M 976M 4 460M 3 350M
interestIncome 0 11M 0 0 0 0 0 72M 74M 0 0 0 0 0
interestExpense 52M 70M 339M 58M 65M 66M 277M 72M 74M 64M 256M 60M 264M 156M
depreciationAndAmortization 176M 169M 662M 170M 162M 166M 694M 140M 136M 134M 682M 167M 716M 517M
ebitda 178M 264M 1 489M 787M 195M 290M -224M 173M 166M 346M 866M 211M 409M 900 000
ebitdaratio 0.157 0.213 0.764 0.234 0.241 0.162 0.157 0.275 0.205
operatingIncome 27M 85M 251M -5M 115M 133M 326M 42M 53M 212M 384M 44M 304M -77M
operatingIncomeRatio 0.024 0.068 -0.005 0.097 0.11 0.039 0.05 0.169 0.043
totalOtherIncomeExpensesNet -77M -60M 237M 564M -147M -55M -1 521M -1 067M -58M -104M -456M -86M -875M -595M
incomeBeforeTax -50M 25M 488M 559M -32M 12M -1 195M -1 097M -79M 108M -72M -42M -571M -672M
incomeBeforeTaxRatio -0.044 0.02 0.543 -0.027 0.01 -1.027 -0.075 0.086 -0.041
incomeTaxExpense -16M 14M 150M 195M 18M -20M 36M -1 000 000 18M 5M 6M 7M -88M -112M
netIncome -34M 11M 338M 364M -50M 32M -1 231M -1 096M -97M 103M -78M -49M -483M -560M
netIncomeRatio -0.03 0.009 0.353 -0.042 0.027 -1.026 -0.092 0.082 -0.048
eps -0.07 0.022 0.68 0.74 -0.1 0.06 -2.5 -2.22 -0.2 0.21 -0.15 -0.1 -0.97 -1.27
epsdiluted -0.07 0.022 0.73 -0.1 0.06 -2.22 -0.2 0.21 -0.1
weightedAverageShsOut 497M 497M 494M 494M 494M 493M 492M 493M 493M 491M 488M 488M 487M 441M
weightedAverageShsOutDil 497M 500M 497M 498M 494M 496M 492M 493M 493M 493M 488M 488M 487M 441M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-25 2024-02-26 2023-03-01 2022-02-28 2021-03-01
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome -339M -277M -256M -264M -156M
ebit 827M -918M 184M -307M -516M
nonOperatingIncomeExcludingInterest -576M 1 244M 200M 611M 439M
netIncomeFromContinuingOperations 338M -1 231M -78M -483M -560M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 338M -1 231M -78M -483M -560M
epsDiluted 0.68 -2.5 -0.15 -0.97 -1.27

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol ELAN ELAN ELAN ELAN ELAN ELAN ELAN ELAN ELAN ELAN ELAN ELAN ELAN ELAN
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-05 2025-08-07 2024-11-07 2024-08-08 2024-05-08 2023-11-07 2023-08-07 2023-05-09 2022-11-08
acceptedDate 2025-11-05 09:06:32 2025-08-07 09:05:13 2025-02-25 09:12:37 2024-11-07 09:07:58 2024-08-08 09:10:02 2024-05-08 09:06:59 2024-02-26 09:05:25 2023-11-07 16:14:47 2023-08-07 16:11:14 2023-05-09 09:08:41 2023-03-01 13:00:26 2022-11-08 09:07:49 2022-02-28 14:46:11 2021-03-01 14:25:10
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 505M 539M 468M 490M 416M 345M 352M 369M 367M 318M 345M 460M 638M 495M
shortTermInvestments 0 0 0 0 0 0 0 0 40M 0 0 0 0 0
cashAndShortTermInvestments 505M 539M 468M 490M 416M 345M 352M 369M 367M 318M 345M 460M 638M 495M
netReceivables 975M 1 103M 886M 904M 1 080M 1 078M 1 010M 1 135M 1 225M 1 264M 1 002M 1 028M 1 028M 1 077M
inventory 1 708M 1 670M 1 574M 1 632M 1 611M 1 638M 1 735M 1 690M 1 690M 1 596M 1 538M 1 340M 1 371M 1 578M
otherCurrentAssets 305M 302M 287M 340M 904M 338M 310M 371M 370M 370M 394M 326M 0 11M
totalCurrentAssets 3 493M 3 614M 3 215M 3 366M 4 011M 4 050M 3 407M 3 565M 3 652M 3 548M 3 279M 3 154M 3 274M 3 417M
propertyPlantEquipmentNet 1 392M 1 357M 993M 979M 949M 949M 1 026M 992M 1 007M 1 000M 999M 936M 1 055M 1 316M
goodwill 4 764M 4 758M 4 414M 4 625M 4 480M 4 478M 5 094M 4 902M 6 040M 6 061M 5 993M 5 716M 6 172M 6 225M
intangibleAssets 3 596M 3 705M 3 681M 4 011M 4 000M 4 196M 4 494M 4 475M 4 678M 4 791M 4 842M 4 766M 5 587M 6 387M
goodwillAndIntangibleAssets 8 360M 8 463M 8 095M 8 636M 8 480M 8 674M 9 588M 9 377M 10 718M 10 852M 10 835M 10 482M 11 759M 12 612M
longTermInvestments 0 14M 0 0 33M 25M 0 60M 87M 0 0 0 0 0
taxAssets 0 0 0 0 4 000M -25M 0 -60M -87M 0 0 0 0 0
otherNonCurrentAssets 306M 294M 311M 302M -3 709M 346M 341M 410M 419M 369M 378M 376M 390M 348M
totalNonCurrentAssets 10 058M 10 128M 9 399M 9 917M 9 753M 9 969M 10 955M 10 779M 12 144M 12 221M 12 212M 11 794M 13 204M 14 276M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 13 551M 13 742M 12 614M 13 283M 13 764M 14 019M 14 362M 14 344M 15 796M 15 769M 15 491M 14 948M 16 478M 17 693M
accountPayables 352M 368M 296M 259M 291M 302M 270M 296M 354M 381M 390M 350M 416M 501M
shortTermDebt 62M 61M 44M 44M 213M 38M 38M 39M 39M 381M 388M 394M 294M 555M
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 0 0 0 0 0 318M 0 356M 0 0 0 0 0 0
otherCurrentLiabilities 1 041M 963M 975M 1 018M 866M 574M 933M 574M 891M 816M 924M 869M 937M 1 021M
totalCurrentLiabilities 1 455M 1 392M 1 315M 1 321M 1 370M 1 232M 1 241M 1 265M 1 284M 1 578M 1 702M 1 613M 1 647M 2 077M
longTermDebt 3 962M 4 148M 4 277M 4 313M 5 463M 5 727M 5 736M 5 870M 6 023M 5 639M 5 448M 5 507M 6 025M 5 572M
deferredRevenueNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 496M 449M 0 524M 530M 567M 643M 658M 663M 662M 618M 765M 900M
otherNonCurrentLiabilities 1 385M 931M 477M 1 126M 465M 474M 595M 432M 411M 409M 390M 5 846M 533M 668M
totalNonCurrentLiabilities 5 347M 5 575M 5 203M 5 439M 6 452M 6 731M 6 898M 6 945M 7 092M 6 711M 6 500M 6 590M 7 323M 7 140M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilities 6 802M 6 967M 6 518M 6 760M 7 822M 7 963M 8 139M 8 210M 8 376M 8 289M 8 202M 8 203M 8 970M 9 217M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
retainedEarnings -1 906M -1 872M -1 950M -1 942M -2 306M -2 256M -2 288M -2 147M -1 051M -954M -1 057M -972M -979M -477M
accumulatedOtherComprehensiveIncomeLoss -199M -192M -771M -339M -542M -465M -266M -482M -281M -310M -392M -1 007M -209M 303M
othertotalStockholdersEquity 8 854M 8 839M 8 804M 8 790M 8 777M 8 763M 8 752M 8 744M 8 724M
totalStockholdersEquity 6 749M 6 775M 6 096M 6 523M 5 942M 6 056M 6 223M 6 134M 7 420M 7 480M 7 289M 6 745M 7 508M 8 476M
totalEquity 6 749M 6 775M 6 096M 6 523M 5 942M 6 056M 6 223M 6 134M 7 420M 7 480M 7 289M 6 745M 7 508M 8 476M
totalLiabilitiesAndStockholdersEquity 13 551M 13 742M 13 283M 13 764M 14 019M 14 344M 15 796M 15 769M 14 948M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 13 551M 13 742M 12 614M 13 283M 13 764M 14 019M 14 362M 14 344M 15 796M 15 769M 15 491M 14 948M 16 478M 17 693M
totalInvestments 0 14M 0 0 33M 25M 0 60M 87M 0 0 0 0 0
totalDebt 4 024M 4 209M 4 321M 4 357M 5 676M 5 765M 5 774M 5 909M 6 062M 6 020M 5 836M 5 901M 6 319M 6 127M
netDebt 3 519M 3 670M 3 853M 3 867M 5 260M 5 420M 5 422M 5 540M 5 695M 5 702M 5 491M 5 441M 5 681M 5 632M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-25 2024-02-26 2023-03-01 2022-02-28 2021-03-01
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 805M 842M 797M 833M 872M
otherReceivables 81M 168M 205M 195M 205M
prepaids 0 0 0 237M 256M
totalPayables 296M 270M 390M 416M 501M
otherPayables 0 0 0 0 0
accruedExpenses 0 0 0 0 0
capitalLeaseObligationsCurrent 0 0 0 0 0
capitalLeaseObligationsNonCurrent 0 0 0 0 0
treasuryStock 0 0 0 0 0
additionalPaidInCapital 8 817M 8 777M 8 738M 8 696M 8 650M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol ELAN ELAN ELAN ELAN ELAN ELAN ELAN ELAN ELAN ELAN ELAN ELAN ELAN ELAN
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-05 2025-08-07 2024-11-07 2024-08-08 2024-05-08 2023-11-07 2023-08-07 2023-05-09 2022-11-08
acceptedDate 2025-11-05 09:06:32 2025-08-07 09:05:13 2025-02-25 09:12:37 2024-11-07 09:07:58 2024-08-08 09:10:02 2024-05-08 09:06:59 2024-02-26 09:05:25 2023-11-07 16:14:47 2023-08-07 16:11:14 2023-05-09 09:08:41 2023-03-01 13:00:26 2022-11-08 09:07:49 2022-02-28 14:46:11 2021-03-01 14:25:10
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome -34M 11M 338M 364M -50M 32M -1 231M -1 096M -97M 103M -78M -49M -472M -574M
depreciationAndAmortization 176M 169M 662M 170M 162M 166M 694M 173M 177M 173M 682M 167M 716M 517M
deferredIncomeTax 0 0 -112M 0 0 0 -80M 1 047M -3M 2M -57M 4M -154M -114M
stockBasedCompensation 17M 20M 55M 15M 14M 11M 46M 10M 9M 12M 59M 13M 66M 47M
changeInWorkingCapital -237M 52M 149M 155M 22M -177M -300M 27M -34M -439M -462M -15M -87M 169M
accountsReceivables 0 0 12M 0 0 0 -40M 0 0 0 14M 0 -3M 24M
inventory 0 0 44M 0 0 0 -160M 0 0 0 -269M 0 27M -95M
accountsPayables 0 0 82M 0 0 0 -94M 0 0 0 -98M 0 -120M 362M
otherWorkingCapital -237M 52M 11M 155M 22M -177M -6M 27M -34M 0 -109M 0 9M -122M
otherNonCashItems 297M -15M -551M -542M 52M 313M 1 142M 37M 9M 4M 308M 69M 414M -86M
netCashProvidedByOperatingActivities 219M 237M 541M 162M 200M 2M 271M 198M 61M -145M 452M 189M 483M -41M
investmentsInPropertyPlantAndEquipment -92M -57M -147M -42M -34M -24M -140M -33M -42M -38M -184M -46M -197M -311M
acquisitionsNet 7M -7M 1 319M 5M 0 -5M -19M -3M 0 -16M 13M 11M -342M -4 567M
purchasesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 -104M
salesMaturitiesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 33M
otherInvestingActivites -16M 8M 1 281M 1 000 000 66M 0 -1 000 000 -1 000 000 -2M
netCashUsedForInvestingActivites -101M -56M 1 244M -33M 37M -36M -43M -55M -37M
debtRepayment -188M -446M -1 332M -92M -13M -506M -13M -19M -154M
commonStockIssued 0 0 0 0 0 0 0 0 0
commonStockRepurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0 0
otherFinancingActivites 35M 290M -8M -1 000 000 -14M 349M 52M 193M -15M
netCashUsedProvidedByFinancingActivities -153M -156M -1 340M -93M -27M -157M 39M 174M -169M
effectOfForexChangesOnCash 1 000 000 27M -91M 8M -3M -19M -12M -3M -8M -1 000 000 -17M -30M -31M 27M
netChangeInCash -34M 52M 116M 74M 71M -7M 7M 2M 49M -27M -293M -47M 132M 160M
cashAtEndOfPeriod 505M 539M 468M 490M 416M 345M 352M 369M 367M 318M 345M 460M 638M 505M
cashAtBeginningOfPeriod 539M 487M 352M 416M 345M 352M 345M 367M 318M 345M 638M 507M 506M 345M
operatingCashFlow 219M 237M 541M 162M 200M 2M 271M 198M 61M -145M 452M 189M 483M -41M
capitalExpenditure -92M -57M -147M -42M -34M -24M -154M -33M -42M -38M -184M -46M -197M -311M
freeCashFlow 127M 180M 394M 120M 166M -22M 117M 165M 19M -183M 268M 143M 286M -352M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-25 2024-02-26 2023-03-01 2022-02-28 2021-03-01
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities -14M -10M -8M 9M 169M
netCashProvidedByInvestingActivities 1 158M -169M -179M -530M -4 779M
netDebtIssuance -1 475M -77M -517M 177M 3 852M
longTermNetDebtIssuance -1 475M -77M -502M 177M 3 852M
shortTermNetDebtIssuance 0 0 -15M 0 0
netStockIssuance 0 0 0 0 1 220M
netCommonStockIssuance 0 0 0 0 1 220M
commonStockIssuance 0 0 0 0 1 220M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -17M -6M -32M 33M -118M
netCashProvidedByFinancingActivities -1 492M -83M -549M 210M 4 954M
incomeTaxesPaid 0 0 0 0 0
interestPaid 0 379M 0 0 0

Earning call transcript

2025 q3
2025-11-05 ET (fiscal 2025 q3)
2025 q2
2025-08-07 ET (fiscal 2025 q2)
2025 q1
2025-05-07 ET (fiscal 2025 q1)
2024 q4
2025-02-25 ET (fiscal 2024 q4)
2024 q3
2024-11-07 ET (fiscal 2024 q3)
2024 q2
2024-08-08 ET (fiscal 2024 q2)
2024 q1
2024-05-08 ET (fiscal 2024 q1)
2023 q4
2024-02-26 ET (fiscal 2023 q4)
2023 q3
2023-11-07 ET (fiscal 2023 q3)
2023 q2
2023-08-07 ET (fiscal 2023 q2)
2023 q1
2023-05-09 ET (fiscal 2023 q1)
2022 q4
2023-02-21 ET (fiscal 2022 q4)
2022 q3
2022-11-08 ET (fiscal 2022 q3)
2022 q2
2022-08-08 ET (fiscal 2022 q2)
2022 q1
2022-05-09 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 10
2025-11-05 14:06 ET
Elanco Animal Health reported for 2025 q3
SEC form 8
2025-11-05 11:30 ET
Elanco Animal Health published news for 2025 q3
SEC form 8
2025-11-05 11:30 ET
Elanco Animal Health published news for 2025 q3
SEC form 10
2025-08-07 13:05 ET
Elanco Animal Health reported for 2025 q2
SEC form 8
2025-08-07 10:27 ET
Elanco Animal Health published news for 2025 q2
SEC form 8
2025-08-07 10:27 ET
Elanco Animal Health published news for 2025 q2
SEC form 10
2025-05-07 13:05 ET
Elanco Animal Health reported for 2025 q1
SEC form 8
2025-05-07 10:30 ET
Elanco Animal Health published news for 2025 q1
SEC form 8
2025-05-07 10:30 ET
Elanco Animal Health published news for 2025 q1
SEC form 10
2025-05-07 00:00 ET
Elanco Animal Health published news for 2025 q1
SEC form 10
2025-02-25 14:12 ET
Elanco Animal Health published news for 2024 q4
SEC form 10
2025-02-25 00:00 ET
Elanco Animal Health reported for 2024 q4
SEC form 8
2025-02-25 00:00 ET
Elanco Animal Health published news for 2024 q4
SEC form 8
2025-02-25 00:00 ET
Elanco Animal Health published news for 2024 q4
SEC form 10
2024-11-07 09:07 ET
Elanco Animal Health reported for 2024 q3
SEC form 8
2024-11-07 06:27 ET
Elanco Animal Health published news for 2024 q3
SEC form 8
2024-11-07 06:27 ET
Elanco Animal Health published news for 2024 q3
SEC form 10
2024-08-08 09:10 ET
Elanco Animal Health reported for 2024 q2
SEC form 8
2024-08-08 06:29 ET
Elanco Animal Health published news for 2024 q2
SEC form 8
2024-08-08 06:29 ET
Elanco Animal Health reported for 2024 q2
SEC form 10
2024-08-08 00:00 ET
Elanco Animal Health reported for 2024 q2
SEC form 10
2024-05-08 09:06 ET
Elanco Animal Health reported for 2024 q1
SEC form 8
2024-05-08 06:28 ET
Elanco Animal Health published news for 2024 q1
SEC form 8
2024-05-08 06:28 ET
Elanco Animal Health reported for 2024 q1
SEC form 10
2024-05-08 00:00 ET
Elanco Animal Health reported for 2024 q1
SEC form 10
2024-02-26 09:05 ET
Elanco Animal Health reported for 2023 q4
SEC form 8
2024-02-26 06:30 ET
Elanco Animal Health published news for 2023 q4
SEC form 8
2024-02-26 06:30 ET
Elanco Animal Health reported for 2023 q4
SEC form 10
2024-02-26 00:00 ET
Elanco Animal Health reported for 2023 q4
SEC form 10
2023-11-07 16:14 ET
Elanco Animal Health reported for 2023 q3
SEC form 8
2023-11-07 06:29 ET
Elanco Animal Health reported for 2023 q3
SEC form 10
2023-11-07 00:00 ET
Elanco Animal Health reported for 2023 q3
SEC form 10
2023-08-07 16:11 ET
Elanco Animal Health reported for 2023 q2
SEC form 6
2023-08-07 06:30 ET
Elanco Animal Health published news for 2023 q2
SEC form 10
2023-08-07 00:00 ET
Elanco Animal Health published news for 2023 q2
SEC form 6
2023-07-13 17:27 ET
Elanco Animal Health published news for 2023 q2
SEC form 6
2023-07-10 16:15 ET
Elanco Animal Health published news for 2023 q2
SEC form 6
2023-07-05 17:12 ET
Elanco Animal Health published news for 2023 q2
SEC form 6
2023-07-05 17:05 ET
Elanco Animal Health published news for 2023 q2
SEC form 10
2023-05-09 00:00 ET
Elanco Animal Health reported for 2023 q1
SEC form 8
2023-05-09 00:00 ET
Elanco Animal Health published news for 2023 q1
SEC form 6
2023-03-24 16:03 ET
Elanco Animal Health published news for 2022 q4
SEC form 6
2023-03-03 21:10 ET
Elanco Animal Health published news for 2022 q4
SEC form 6
2023-03-03 21:08 ET
Elanco Animal Health published news for 2022 q4
SEC form 6
2023-03-03 21:07 ET
Elanco Animal Health published news for 2022 q4
SEC form 6
2023-03-03 21:06 ET
Elanco Animal Health published news for 2022 q4
SEC form 6
2023-03-03 21:00 ET
Elanco Animal Health published news for 2022 q4
SEC form 6
2023-03-03 20:59 ET
Elanco Animal Health published news for 2022 q4
SEC form 6
2023-03-03 20:59 ET
Elanco Animal Health published news for 2022 q4
SEC form 6
2023-03-03 20:55 ET
Elanco Animal Health published news for 2022 q4
SEC form 10
2023-03-01 13:00 ET
Elanco Animal Health reported for 2022 q4
SEC form 6
2023-03-01 12:39 ET
Elanco Animal Health published news for 2022 q4
SEC form 10
2023-03-01 00:00 ET
Elanco Animal Health reported for 2022 q4
SEC form 6
2023-02-21 06:30 ET
Elanco Animal Health published news for 2022 q4
SEC form 8
2023-02-21 00:00 ET
Elanco Animal Health reported for 2022 q4
SEC form 6
2023-02-03 16:06 ET
Elanco Animal Health published news for 2022 q4
SEC form 6
2023-01-31 16:05 ET
Elanco Animal Health published news for 2022 q4
SEC form 6
2023-01-09 08:01 ET
Elanco Animal Health published news for 2022 q4
SEC form 6
2023-01-05 18:32 ET
Elanco Animal Health published news for 2022 q4
SEC form 6
2022-12-02 17:12 ET
Elanco Animal Health published news for 2022 q3
SEC form 6
2022-12-02 17:10 ET
Elanco Animal Health published news for 2022 q3
SEC form 6
2022-12-02 17:08 ET
Elanco Animal Health published news for 2022 q3
SEC form 6
2022-12-02 17:06 ET
Elanco Animal Health published news for 2022 q3
SEC form 6
2022-12-02 17:05 ET
Elanco Animal Health published news for 2022 q3
SEC form 6
2022-12-02 17:04 ET
Elanco Animal Health published news for 2022 q3
SEC form 10
2022-11-08 09:07 ET
Elanco Animal Health published news for 2022 q3
SEC form 6
2022-11-08 06:57 ET
Elanco Animal Health published news for 2022 q3
SEC form 10
2022-11-08 00:00 ET
Elanco Animal Health reported for 2022 q3
SEC form 8
2022-11-08 00:00 ET
Elanco Animal Health reported for 2022 q3
SEC form 6
2022-11-03 18:45 ET
Elanco Animal Health published news for 2022 q3
SEC form 6
2022-09-08 08:05 ET
Elanco Animal Health published news for 2022 q2
SEC form 10
2022-08-08 09:05 ET
Elanco Animal Health published news for 2022 q2
SEC form 6
2022-08-08 07:00 ET
Elanco Animal Health published news for 2022 q2
SEC form 10
2022-08-08 00:00 ET
Elanco Animal Health reported for 2022 q2
SEC form 8
2022-08-08 00:00 ET
Elanco Animal Health reported for 2022 q2
SEC form 6
2022-07-06 18:03 ET
Elanco Animal Health published news for 2022 q2
SEC form 6
2022-06-29 16:15 ET
Elanco Animal Health published news for 2022 q1
SEC form 6
2022-05-19 17:01 ET
Elanco Animal Health published news for 2022 q1
SEC form 10
2022-05-09 09:08 ET
Elanco Animal Health published news for 2022 q1
SEC form 6
2022-05-09 07:01 ET
Elanco Animal Health published news for 2022 q1
SEC form 10
2022-05-09 00:00 ET
Elanco Animal Health reported for 2022 q1
SEC form 8
2022-05-09 00:00 ET
Elanco Animal Health reported for 2022 q1
SEC form 6
2022-04-20 16:11 ET
Elanco Animal Health published news for 2022 q1
SEC form 6
2022-04-13 06:15 ET
Elanco Animal Health published news for 2022 q1
SEC form 6
2022-04-06 16:17 ET
Elanco Animal Health published news for 2022 q1
SEC form 6
2022-04-05 18:03 ET
Elanco Animal Health published news for 2022 q1
SEC form 6
2022-03-29 17:13 ET
Elanco Animal Health published news for 2021 q4
SEC form 6
2022-03-24 16:14 ET
Elanco Animal Health published news for 2021 q4
SEC form 6
2022-03-03 21:03 ET
Elanco Animal Health published news for 2021 q4
SEC form 6
2022-03-03 21:00 ET
Elanco Animal Health published news for 2021 q4
SEC form 6
2022-03-03 16:05 ET
Elanco Animal Health published news for 2021 q4
SEC form 10
2022-02-28 14:46 ET
Elanco Animal Health published news for 2021 q4
SEC form 10
2022-02-28 00:00 ET
Elanco Animal Health published news for 2021 q4
SEC form 6
2022-02-24 06:31 ET
Elanco Animal Health published news for 2021 q4
SEC form 8
2022-02-24 00:00 ET
Elanco Animal Health published news for 2021 q4
SEC form 6
2022-01-14 08:13 ET
Elanco Animal Health published news for 2021 q4
SEC form 6
2022-01-10 06:16 ET
Elanco Animal Health published news for 2021 q4
SEC form 8
2022-01-10 00:00 ET
Elanco Animal Health published news for 2021 q4
SEC form 6
2022-01-06 16:16 ET
Elanco Animal Health published news for 2021 q4
SEC form 6
2021-11-30 07:10 ET
Elanco Animal Health published news for 2021 q3
SEC form 10
2021-11-05 08:58 ET
Elanco Animal Health published news for 2021 q3
SEC form 6
2021-11-05 06:40 ET
Elanco Animal Health published news for 2021 q3
SEC form 10
2021-11-05 00:00 ET
Elanco Animal Health published news for 2021 q3
SEC form 8
2021-11-05 00:00 ET
Elanco Animal Health published news for 2021 q3
SEC form 6
2021-10-05 06:36 ET
Elanco Animal Health published news for 2021 q3
SEC form 6
2021-08-30 09:01 ET
Elanco Animal Health published news for 2021 q2
SEC form 6
2021-08-12 16:49 ET
Elanco Animal Health published news for 2021 q2
SEC form 10
2021-08-09 09:11 ET
Elanco Animal Health published news for 2021 q2
SEC form 6
2021-08-09 06:48 ET
Elanco Animal Health published news for 2021 q2
SEC form 10
2021-08-09 00:00 ET
Elanco Animal Health published news for 2021 q2
SEC form 8
2021-08-09 00:00 ET
Elanco Animal Health published news for 2021 q2
SEC form 6
2021-08-02 09:03 ET
Elanco Animal Health published news for 2021 q2
SEC form 6
2021-07-01 09:00 ET
Elanco Animal Health published news for 2021 q2
SEC form 6
2021-06-16 07:01 ET
Elanco Animal Health published news for 2021 q1
SEC form 6
2021-06-09 16:10 ET
Elanco Animal Health published news for 2021 q1
SEC form 6
2021-06-04 08:10 ET
Elanco Animal Health published news for 2021 q1
SEC form 6
2021-05-21 16:02 ET
Elanco Animal Health published news for 2021 q1
SEC form 10
2021-05-07 09:11 ET
Elanco Animal Health published news for 2021 q1
SEC form 6
2021-05-07 06:42 ET
Elanco Animal Health published news for 2021 q1
SEC form 6
2021-05-07 06:40 ET
Elanco Animal Health published news for 2021 q1
SEC form 10
2021-05-07 00:00 ET
Elanco Animal Health published news for 2021 q1
SEC form 8
2021-05-07 00:00 ET
Elanco Animal Health published news for 2021 q1
SEC form 6
2021-03-25 16:26 ET
Elanco Animal Health published news for 2020 q4
SEC form 10
2021-03-01 14:25 ET
Elanco Animal Health published news for 2020 q4
SEC form 6
2021-02-24 06:45 ET
Elanco Animal Health published news for 2020 q4
SEC form 6
2021-02-22 17:48 ET
Elanco Animal Health published news for 2020 q4
SEC form 6
2021-01-26 08:19 ET
Elanco Animal Health published news for 2020 q4
SEC form 6
2021-01-11 15:20 ET
Elanco Animal Health published news for 2020 q4
SEC form 6
2020-12-17 16:40 ET
Elanco Animal Health published news for 2020 q3
SEC form 6
2020-12-15 08:07 ET
Elanco Animal Health published news for 2020 q3
SEC form 6
2020-12-15 06:02 ET
Elanco Animal Health published news for 2020 q3
SEC form 6
2020-12-03 16:11 ET
Elanco Animal Health published news for 2020 q3
SEC form 6
2020-12-01 06:09 ET
Elanco Animal Health published news for 2020 q3
SEC form 6
2020-11-30 07:20 ET
Elanco Animal Health published news for 2020 q3
SEC form 6
2020-11-23 16:10 ET
Elanco Animal Health published news for 2020 q3
SEC form 10
2020-11-06 16:12 ET
Elanco Animal Health published news for 2020 q3
SEC form 6
2020-11-06 06:39 ET
Elanco Animal Health published news for 2020 q3
SEC form 6
2020-10-15 16:47 ET
Elanco Animal Health published news for 2020 q3
SEC form 6
2020-09-30 07:37 ET
Elanco Animal Health published news for 2020 q2